1. Bosco Julian J
2. Fulcher David A

9789350252710

10.5005/jp/books/11215_20

1/e

2011

13

1. Westmead Hospital, Westmead, Sydney, Australia
2. University of Sydney; ICPMR; Westmead Hospital, Westmead, Sydney, Australia

Catastrophic antiphospholipid syndrome, thromboses, antiphospholipid antibodies, phospholipid antigens, Sjögren’s syndrome, thrombocytopenia, anticardiolipin antibodies, lupus anticoagulant, anti-β2 glycoprotein I (β2GPI) antibodies, cytomegalovirus, polymorphisms, anticoagulants, tissue hypoxia, thrombotic microangiopathies, disseminated intravascular coagulation, plasminogen activator inhibitor-1, antiphospholipid tests, microvascular thrombosis, vascular thrombose, SLE flares, alveolar hemorrhage, thrombotic microangiopathy, hemolysis, activated partial thromboplastin time, Coomb’s positive hemolytic anemia, plasma exchange, corticosteroids, ancillary agent, intravenous immunoglobulin, cyclophosphamide, combination therapy, rituximab, mortality rate, intravenous heparin